期刊
JOURNAL OF ORTHOPAEDIC RESEARCH
卷 28, 期 12, 页码 1586-1599出版社
WILEY
DOI: 10.1002/jor.21173
关键词
cartilage; osteoarthritis; osteochondral autografting; animal model; mesenchymal stem cells
类别
Mesenchymal stem cells (MSC) are increasingly replacing chondrocytes in tissue engineering based research for treatment of osteochondral defects The aim of this work was to determine whether repair of critical size chronic osteochondral defects in an ovine model using MSC seeded triphasic constructs would show results comparable to osteochondral autografting (OATS) Triphasic implants were engineered using a beta tricalcium phosphate osseous phase an intermediate activated plasma phase, and a collagen I hydrogel chondral phase Autologous MSCs were used to seed the implants with chondrogenic predifferentiation of the cells used in the cartilage phase Osteochondral defects of 4 0 mm diameter were created bilaterally in ovine knees (n = 10) Six weeks later, half of the lesions were treated with OATS and half with triphasic constructs The knees were dissected at 6 or 12 months With the chosen study design we were not able to demonstrate significant differences between the histological scores of both groups Subcategory analysis of O'Driscoll scores showed superior cartilage bonding in the 6 month triphasic group compared to the autograft group The 12 month autograft group showed superior cartilage matrix morphology compared to the 12 month triphasic group Macroscopic and biomechanical analysis showed no significant differences at 12 months Autologous MSC seeded triphasic implants showed comparable repair quality to osteochondral autografts in terms of histology and biomechanical testing (c) 2010 Orthopaedic Research Society Published by Wiley Periodicals Inc J Orthop Res 28 1586-1599 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据